Stockreport

Revance Appoints Mark J. Foley as President and CEO, Replacing Dan Browne

Revance Therapeutics, Inc.  (RVNC) 
Last revance therapeutics, inc. earnings: 2/24 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.revance.com
PDF - Mark Foley to lead company as it gears up to commercialize next-generation neuromodulator –- Change in leadership unrelated to company performance -- Revance on track [Read more]